Housset M, Baillet F, Michelson A M, Puget K
Service d'Electroradiologie, Hôpital Necker, Paris.
Ann Med Interne (Paris). 1989;140(5):365-7.
Radiation-induced fibroses are a classical complication of radiotherapy. We have studied the effect of liposomal superoxide dismutase (Lipsod) on 45 radiation-induced fibroses of measurable volume and hardness in 34 patients. Over 3 weeks, 6 injections of Lipsod were given intramuscularly: 5 mg for 28 patients and 2 mg for 6 patients. On the average, the volume decreased by 32%. A marked or moderate softening was observed in 80% of the fibroses; it was accompanied by functional improvement in 75% of the patients (in cases of preexisting difficulties). The effectiveness was independent of the time lag between the Lipsod treatment and irradiation. The decreases noted in the volume and hardness of the fibroses remained stable during a follow-up of 5-24 months. This systematic study shows the interest of Lipsod treatment of quasi-experimental fibroses where no other effective therapy exists.
放射性纤维化是放射治疗的一种典型并发症。我们研究了脂质体超氧化物歧化酶(Lipsod)对34例患者中45处可测量体积和硬度的放射性纤维化的影响。在3周内,通过肌肉注射给予6次Lipsod:28例患者注射5毫克,6例患者注射2毫克。平均而言,体积减少了32%。在80%的纤维化中观察到明显或中度软化;75%的患者(存在先前困难的病例)功能得到改善。疗效与Lipsod治疗和放疗之间的时间间隔无关。在5至24个月的随访期间,纤维化的体积和硬度下降保持稳定。这项系统性研究表明,在不存在其他有效治疗方法的情况下,Lipsod治疗准实验性纤维化具有一定价值。